SITC Clinical Practice Guideline Webinars – Multiple MyelomaA pair of free, hour-long webinars on cancer immunotherapy for multiple myeloma are coming up soon. Advance your understanding with practical management pearls and case-based learning led by expert panel authors from SITC’s clinical practice guideline on April 23 at 5 p.m. ET and June 16 at 5 p.m. ET.
Current members can now submit nominees for 2021 and 2022 SITC Annual Awards. Nominations due by April 20.
Meet the six candidates in the 2021 SITC Election, taking place April 21–May 5, 2021.
SITC is pleased to announce two award opportunities that will assist early career investigators in advancing their cancer immunotherapy research by leveraging spatial technology platforms. Applications are due May 13 by 11:59 p.m. EST.
Attend the SITC Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop, Sept. 29–30, 2021, in San Diego. This SITC workshop will focus on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and the maximization of existing techniques.
Comprised of several authoritative reviews of COVID-19 and Cancer Immunotherapy, this series, edited by Paolo Antonio Ascierto, MD and Jason D. Goldman, MD, MPH, will explore basic insights into the immunology of the novel coronavirus, repurposing of immune-based therapies including the effects of immune-oncology agents, and the affected cancer populations.
The Biomarkers Subcommittees, Clinical and Biomarkers Data Sharing, Resources and Useful Tools are pleased to announce publication of three manuscripts that encompass the state of the field and a look to the future.
SITC President Patrick Hwu, MD, recently sat down with BioNTech CEO Ugur Sahin, MD, discussing a range of topics, including the process to develop the SARS-CoV-2 vaccine in 11 months
Access SITC Surgery Committee’s Recent JITC Publication“Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee”
In Module 3, Immune Checkpoint Blockade, participants will cover the biological foundation of immune checkpoint blockade therapies as well as diving into their clinical use.
Now Available: SITC Clinical Practice Guideline on Immunotherapy for the Treatment of Lymphoma
Join Brianna Hoffner, MSN, ANP-BC, AOCNP, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.
New Online Patient Course Available: Understanding Cancer Immunotherapy Access SITC’s dedicated resource for patients and caregivers to learn about cancer immunotherapy
Explore resources and educational opportunities for cancer patients and those who advocate for them.
Track the latest advancements and educational opportunities in tumor immunology and cancer immunotherapy.
Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.
Presentations from the 2019-2020 Advances in Cancer Immunotherapy™ Series – Washington, DC virtually held on October 8, 2020 are now available in the SITC Resource Library. Click here to access ACI – DC presentations. You can also reach these materials ...
If you are a PhD or PostDoc researching Cancer Immunotherapies, submit your abstract for a chance to speak at our Cancer Immunotherapy meeting on the 29th of April and receive a prize of $250. Confirmed Keynote speakers are Dr John Maher from Kings ...
Pancreas and Related Cancers - Virtual Meeting June 11, 2021
Presented by the Jefferson Pancreas, Biliary, and Related Cancer Center, this conference is specifically designed for health care professionals ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com